Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Green Chemistry and Coronavirus Publisher



Ahmadi S1 ; Rabiee N2 ; Fatahi Y3, 4, 5 ; Hooshmand SE6 ; Bagherzadeh M2 ; Rabiee M7 ; Jajarmi V9, 10 ; Dinarvand R3, 4 ; Habibzadeh S11 ; Saeb MR12 ; Varma RS13 ; Shokouhimehr M8 ; Hamblin MR14
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Department of Chemistry, Sharif University of Technology, Tehran, Iran
  3. 3. Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Universal Scientific Education and Research Center (USERN), Tehran, Iran
  6. 6. Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran
  7. 7. Biomaterial Group, Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran
  8. 8. Department of Materials Science and Engineering, Research Institute of Advanced Materials, Seoul National University, Seoul, 08826, South Korea
  9. 9. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  10. 10. Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  11. 11. Department of Chemical Engineering, Amirkabir University of Technology, Tehran, Iran
  12. 12. Universite de Lorraine, CentraleSupelec, LMOPS, Metz, F-57000, France
  13. 13. Regional Centre of Advanced Technologies and Materials, Palacky University, Slechtitelu 27, Olomouc, 783 71, Czech Republic
  14. 14. Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, 2028, South Africa

Source: Sustainable Chemistry and Pharmacy Published:2021


Abstract

The novel coronavirus pandemic has rapidly spread around the world since December 2019. Various techniques have been applied in identification of SARS-CoV-2 or COVID-19 infection including computed tomography imaging, whole genome sequencing, and molecular methods such as reverse transcription polymerase chain reaction (RT-PCR). This review article discusses the diagnostic methods currently being deployed for the SARS-CoV-2 identification including optical biosensors and point-of-care diagnostics that are on the horizon. These innovative technologies may provide a more accurate, sensitive and rapid diagnosis of SARS-CoV-2 to manage the present novel coronavirus outbreak, and could be beneficial in preventing any future epidemics. Furthermore, the use of green synthesized nanomaterials in the optical biosensor devices could leads to sustainable and environmentally-friendly approaches for addressing this crisis. © 2021
Other Related Docs
9. Serological and Molecular Tests for Covid-19: A Recent Update, Iranian Journal of Immunology (2021)
18. Microfluidic Devices for Pathogen Detection, Biomedical Applications of Microfluidic Devices (2020)
19. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
24. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
32. The Effect of Hiv/Aids Infection on the Clinical Outcomes of Covid-19: A Meta-Analysis, Journal of Pharmacy and Pharmaceutical Sciences (2022)
34. Covid-19: Significance of Antibodies, Human Antibodies (2020)
46. Crispr/Cas13: A Potential Therapeutic Option of Covid-19, Biomedicine and Pharmacotherapy (2020)
47. Review on Oxidative Stress Relation on Covid-19: Biomolecular and Bioanalytical Approach, International Journal of Biological Macromolecules (2021)
48. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
50. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)